Mukesh Ambani builds an armamentarium against the pathogen which has ravaged India in the past year.India’s most-valuable company is exploring use of a tapeworm drug, Niclosamide, as a cure for Covid-19, according to its annual report.
Its diagnostic kits -- R-Green and R-Green Pro -- have been approved by India’s apex medical research body and it has designed a process to make sanitizers at one-fifth the market cost, Reliance said in the report.The refining-to-retail group’s efforts come as India emerges the pandemic’s epicenter with the world’s fastest-surging coronavirus outbreak that has sickened 28.44 million so far and killed more than 337,900 people in the Asian nation.